• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B3 filed by Saratoga Investment Corp New

    7/19/23 2:19:18 PM ET
    $SAR
    Investment Managers
    Finance
    Get the next $SAR alert in real time by email
    424B3 1 ea182007-424b3_saratoga.htm PROSPECTUS SUPPLEMENT

    Filed pursuant to Rule 424(b)(3)

    File No. 333-269186

     

    Saratoga Investment Corp.

     

    Up to $300,000,000

    Common Stock

    Supplement No. 2, dated July 19, 2023

    to

    Prospectus, dated March 13, 2023 and

    Prospectus Supplement, dated June 7, 2023

     

    This supplement amends, supplements or modifies certain information contained in the prospectus supplement, dated June 7, 2023 (the “ATM Prospectus Supplement”), and the accompanying prospectus, dated March 13, 2023 (the “Base Prospectus,” and together with the ATM Prospectus Supplement, any supplement thereto, and the documents deemed incorporated by reference in each, the “Prospectus”), which relate to the sale of shares of common stock of Saratoga Investment Corp. in an “at-the-market” offering (the “ATM Program”) pursuant to that certain equity distribution agreement (as described below). The terms “we,” “us,” and “our” refer to Saratoga Investment Corp. and its subsidiaries, unless indicated otherwise.

     

    You should carefully read the entire Prospectus and this supplement before investing in our common stock. This supplement should be read in conjunction with the Prospectus. You should also carefully consider the information set forth under the sections entitled “Risk Factors” on page S-7 of the ATM Prospectus Supplement, page 11 of the Base Prospectus and in our Annual Report on Form 10-K for the fiscal year ended February 28, 2023, which is incorporated by reference into the Prospectus, as well as in our subsequent filings with the Securities and Exchange Commission that are incorporated into the Prospectus, before investing in our common stock.  

     

    On July 30, 2021, we established the ATM Program to which the Prospectus relates, and through which we may sell, from time to time through distribution agents, shares of our common stock. When established, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc. (“Ladenburg”) and Compass Point Research and Trading, LLC (“Compass Point”) to sell, from time to time, shares of our common stock under the ATM Program.

     

    This supplement is being filed to reflect that, on July 19, 2023, we added one additional distribution agent to the ATM Program, Raymond James & Associates, Inc. (“Raymond James” and, together with Ladenburg and Compass Point, the “Agents”). In connection with the addition of Raymond James as a distribution agent, we entered into the amendment no. 3, dated July 19, 2023, to the equity distribution agreement with Ladenburg, Compass Point, and Raymond James.

     

    In light of the above, each reference to the term “Agent” or “Agents” in the ATM Prospectus Supplement is hereby amended to include Ladenburg, Compass Point, and Raymond James.

    Get the next $SAR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SAR

    DatePrice TargetRatingAnalyst
    6/9/2025$24.25Buy → Neutral
    Compass Point
    5/13/2025$23.50Neutral
    B. Riley Securities
    10/10/2024Buy → Neutral
    Ladenburg Thalmann
    7/11/2024$24.75Neutral → Buy
    Compass Point
    5/8/2024Outperform → Perform
    Oppenheimer
    1/10/2024Buy → Neutral
    Compass Point
    1/8/2024$28.00Buy → Neutral
    B. Riley Securities
    10/11/2023$27.00Outperform → Market Perform
    Hovde Group
    More analyst ratings

    $SAR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Oberbeck Christian L gifted 11,180 shares and received a gift of 6,708 shares, decreasing direct ownership by 2% to 655,161 units (SEC Form 4)

      4 - SARATOGA INVESTMENT CORP. (0001377936) (Issuer)

      12/15/23 8:49:14 AM ET
      $SAR
      Investment Managers
      Finance
    • SEC Form 4: Oberbeck Christian L disposed of 26,495 shares, decreasing direct ownership by 4% to 666,341 units

      4 - SARATOGA INVESTMENT CORP. (0001377936) (Issuer)

      8/18/23 7:09:44 AM ET
      $SAR
      Investment Managers
      Finance
    • SEC Form 4 filed by Oberbeck Christian L

      4 - SARATOGA INVESTMENT CORP. (0001377936) (Issuer)

      5/8/23 2:54:24 PM ET
      $SAR
      Investment Managers
      Finance